FN1 and cancer: Based on these findings, as well as the ones described in this study, we propose that targeting tumor fibronectin could not only suppress cancer growth but also prevent the formation of the pre-metastatic niche and consequent metastatic invasion, opening up a wide range of therapeutic possibilities.